BackAltamira Therapeutics Overview

Altamira Therapeutics Current Cash

Track Altamira Therapeutics's current cash ($1M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$998624.00
↑ 61.74% YoYΔ $381215.00 vs prior year quarter

Peer average

Loading

Altamira Therapeutics Current Cash History

Loading

Altamira Therapeutics vs. peers: Current Cash Comparison

Loading

Altamira Therapeutics Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Altamira Therapeutics (CYTO) FAQ

Altamira Therapeutics (CYTO) currently reports a current cash of $1M as of December 2024. That compares with $620K in the prior-year period — up 61.7% year over year. Use the charts on this page to explore Altamira Therapeutics's current cash history and peer comparisons.

Altamira Therapeutics's current cash increased from $620K to $1M — a 61.7% year-over-year increase (period ending December 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Altamira Therapeutics reported $1M in current cash as of December 2024. That compares with $620K in the prior-year period — up 61.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $1M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Altamira Therapeutics, and consider following CYTO for alerts when major investors trade the stock.

Altamira Therapeutics is classified in the Healthcare sector. On current cash, it currently shows $1M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CYTO with unrelated industries.